Unknown OBSERVATIONAL NCT03805191

A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients (FLAT)

A Multicentre Observational Study to Investigate the Improvement in Glucose FLuctuation of Sufficient Acarbose Therapy on Type 2 Diabetes Patient With High Blood Glucose Fluctuation

Sponsor: Bayer

Conditions Poor Glycemic Control Type 2 Diabetes Mellitus

Updated 6 times since 2019 Last updated: Apr 11, 2019 Started: Jan 1, 2019 Primary completion: Nov 30, 2020 Completion: Dec 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Poor Glycemic Control and Type 2 Diabetes Mellitus and is currently ongoing. Bayer leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2023 [monthly]

Recruiting
May 2019 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Feb 2019 — May 2019 [monthly]

Not Yet Recruiting

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer
Qilu Hospital of Shandong University

Data source: Qilu Hospital of Shandong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jinan, China